WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) said that it expects its full year 2021 non-GAAP operating loss to be substantially improved relative to the prior year.As of on December
BASEL (dpa-AFX) - Alnylam Pharmaceuticals, Inc. (ALNY) announced a collaboration with Novartis to leverage Alnylam's siRNA technology to inhibit a target discovered at the Novartis Institutes for
WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals, Inc. (ALNY), a RNAi therapeutics company, said on Tuesday that it has elevated Akshay Vaishnaw as its new President. Vaishnaw has been serving the
WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals, Inc. (ALNY) has submitted a Clinical Trial Authorization application to The Medicines and Healthcare Products Regulatory Agency in the United Kingdom